BYSI Stock Summary and Trading Ideas (Beyondspring - | NASDAQ:BYSI)

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.

Beyondspring - trades on the NASDAQ stock market under the symbol BYSI.

As of March 3, 2025, BYSI stock price declined to $1.68 with 8,776 million shares trading.

BYSI has a beta of 1.95, meaning it tends to be more sensitive to market movements. BYSI has a correlation of 0.07 to the broad based SPY ETF.

BYSI has a market cap of $67.70 million. This is considered a Micro Cap stock.

In the last 3 years, BYSI traded as high as $4.00 and as low as $.54.

The top ETF exchange traded funds that BYSI belongs to (by Net Assets): IWC.

BYSI has outperformed the market in the last year with a price return of +30.2% while the SPY ETF gained +16.7%. However, in the short term, BYSI had mixed performance relative to the market. It has underperformed in the last 3 months, returning -11.1% vs -2.2% return in SPY. But in the last 2 weeks, BYSI shares have fared better than the market returning -1.8% compared to SPY -4.3%.

BYSI support price is $1.61 and resistance is $1.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BYSI shares will trade within this expected range on the day.